U45-33057-48280
2 vaccinations
1 coded response
7 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 112 / NY
- Registered
- 2022-01-13
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-12-16
Dose 1 — Moderna
-
2022-01-13
Registered in v-safe
-
2022-01-13
Dose 2 — Moderna
-
2022-01-13
Health check-in — day 0, dose 2Feeling: Good · Site: Pain, Swelling · Headache, NauseaAdult check-in
- 2022-01-18
-
2022-01-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2022-01-20
- 2022-01-30
-
2022-02-05
Survey response — day 21, dose 2MedDRA: Office visit, Rash — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Rash to upper body 2 weeks now · Healthcare visit (other): DoctorMedDRA releases: 2024-11 · check-in free text available
-
2022-02-05
Report sent to call center — day 21, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2022-02-10
- 2022-03-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-12-16 | Moderna | No |
| 2 | 2022-01-13 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 11 — day 21, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Rash | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release